Sinclair Andrew

DirectorAdicet Bio, Inc. (ACET) · full profile →Form 4 · filed Aug 23, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
0 non-derivative · 10 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 21, 2024Disposed to issuer(D)29K$00
Aug 21, 2024Grant(A)29K$029K
Aug 21, 2024Grant(A)26K$026K
Aug 21, 2024Disposed to issuer(D)26K$00
Aug 21, 2024Grant(A)19K$019K
Aug 21, 2024Disposed to issuer(D)19K$00
Aug 21, 2024Grant(A)8K$08K
Aug 21, 2024Disposed to issuer(D)8K$00
Aug 21, 2024Grant(A)19K$019K
Aug 21, 2024Disposed to issuer(D)19K$00

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-100180) within minutes of acceptance. Every field above traces to the original document. Verify it directly: